Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
49 hedge funds and large institutions have $70.9M invested in Tobira Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
17% more funds holding
Funds holding: 42 → 49 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
31% less capital invested
Capital invested by funds: $103M → $70.9M (-$31.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$4.77M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.46M |
| 4 |
Morgan Stanley
New York
|
+$846K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$645K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPV
Canaan Partners VII
Westport,
Connecticut
|
-$8.23M |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$435K |
| 3 |
Goldman Sachs
New York
|
-$423K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$314K |
| 5 |
State Street
Boston,
Massachusetts
|
-$134K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| – | -$1.54K | -110 | -91% |
|
52
Barclays
London,
United Kingdom
| – | -$491 | -35 | -74% |
|
TBRA Hedge Fund Activity: Q3 2015 in Review
49 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q3 2015, worth a combined $70.9M — down 31% from $103M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TBRA positions and 3 closed out — a net gain of 7 holders — while 16 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $18M. The largest seller was Canaan Partners VII, cutting an estimated $8.23M.
- 49 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q3 2015, up from 42 in Q2 2015.
- Funds reported $70.9M of Tobira Therapeutics, Inc. Common Stock stock for Q3 2015, down 31% quarter-over-quarter.
- 10 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q3 2015 and 3 closed out, a net change of +7 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $18M added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q3 2015 was Canaan Partners VII, an estimated $8.23M sold.
Based on aggregated 13F filings for Q3 2015.